Iambic Therapeutics, Inc. Common Stock
IAM Real Time Price USDRecent trades of IAM by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in IAM holdings by institutional investors
Quarterly net insider trading by IAM's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Former government officials who have lobbied for IAM
IAM Estimated quarterly lobbying spending
IAM Revenue by Segment or Geography
New IAM patent grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded to IAM from public contracts
Recent insights relating to IAM
Pending bills that may affect IAM
|
Bill
|
Impact
|
Confidence
|
Date
|
|---|
Recent picks made for IAM stock on CNBC
ETFs with the largest estimated holdings in IAM
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $IAM stock a Buy, Sell, or Hold?
- What is the price target for $IAM stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $IAM stock?
- Who owns the most shares of $IAM stock?
- What funds own $IAM stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IAM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
Iambic Therapeutics, Inc. Common Stock (IAM) Historical Stock Prices
Iambic Therapeutics, Inc. Common Stock (IAM) closed at $13.10 on November 13, 2026. Over the past year its adjusted close ranged from $10.17 to $23.81. Daily prices go back to October 9, 2017, 186 trading days in all.
- 1 month+47.86%
- 3 months+47.86%
- Year to date+47.86%
- 1 year+47.86%
- 3 years+47.86%
- 5 years+47.86%
- Max+33.67%
Quiver Premium charts IAM's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | 15.06 | 15.06 | 12.68 | 13.10 | 13.10 | 278,030 |
| Nov 12, 2026 | 15.39 | 15.39 | 14.02 | 14.84 | 14.84 | 490,506 |
| Nov 11, 2026 | 14.87 | 15.85 | 13.96 | 15.38 | 15.38 | 364,830 |
| Nov 10, 2026 | 14.47 | 15.01 | 12.80 | 14.78 | 14.78 | 867,820 |
| Nov 9, 2026 | 10.06 | 13.47 | 9.90 | 13.38 | 13.38 | 899,208 |
| Nov 6, 2026 | 11.52 | 11.84 | 9.60 | 10.17 | 10.17 | 672,498 |
| Nov 5, 2026 | 13.16 | 13.22 | 10.55 | 11.64 | 11.64 | 751,872 |
| Nov 4, 2026 | 13.80 | 13.96 | 13.15 | 13.40 | 13.40 | 293,881 |
| Nov 3, 2026 | 13.10 | 13.74 | 12.43 | 13.49 | 13.49 | 220,502 |
| Nov 2, 2026 | 13.43 | 13.55 | 12.02 | 12.96 | 12.96 | 402,697 |
| Oct 30, 2026 | 13.10 | 13.57 | 12.39 | 13.43 | 13.43 | 476,854 |
| Oct 29, 2026 | 14.79 | 14.96 | 13.76 | 14.28 | 14.28 | 270,815 |
| Oct 28, 2026 | 13.84 | 16.50 | 13.60 | 14.78 | 14.78 | 926,308 |
| Oct 27, 2026 | 14.41 | 14.90 | 13.51 | 14.00 | 14.00 | 439,754 |
| Oct 26, 2026 | 14.40 | 15.25 | 14.00 | 14.41 | 14.41 | 149,160 |
| Oct 23, 2026 | 14.50 | 14.64 | 13.02 | 14.26 | 14.26 | 610,324 |
| Oct 22, 2026 | 15.40 | 15.47 | 14.50 | 14.67 | 14.67 | 497,477 |
| Oct 21, 2026 | 15.50 | 17.06 | 15.00 | 15.80 | 15.80 | 479,331 |
| Oct 20, 2026 | 16.31 | 17.50 | 15.00 | 16.01 | 16.01 | 981,186 |
| Oct 19, 2026 | 21.00 | 21.54 | 14.10 | 16.34 | 16.34 | 2,388,424 |
| Oct 16, 2026 | 19.31 | 25.00 | 19.31 | 23.81 | 23.81 | 2,964,854 |
| Oct 15, 2026 | 16.15 | 19.70 | 16.15 | 18.91 | 18.91 | 2,015,121 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at IAM, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|